Results 261 to 270 of about 40,773 (330)

Author response: SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion

, 2013
Xiaowei Chen, He Wang, Kanika Bajaj Pahuja, Pengcheng Zhang, Zhuo-Xian Meng, Danjun Ma, Yongsheng Bai, Huihui Liu, Elizabeth Adams, Andrea C. Baines, Genggeng Yu, Maureen A. Sartor, Bin Zhang, Zhengping Yi, Jiandie D. Lin, Stephen G. Young, Randy Schekman, David Ginsburg   +17 more
openalex   +1 more source

Reduction in PCSK9 levels induced by anacetrapib: an off-target effect? [PDF]

, 2015
Philip J. Barter, Fatiha Tabet, Kerry‐Anne Rye   +2 more
openalex   +1 more source

PCSK9-antibodies fail to block PCSK9-induced inflammation in macrophages and cannot recapitulate protective effects of PCSK9-deficiency in experimental myocardial infarction. [PDF]

Front Cardiovasc Med
Rauterberg S, Härdtner C, Hein J, Schrepf P, Peyronnet R, Koentges C, Vico TA, Ehlert C, Dufner B, Lindner D, von Zur Mühlen C, Wolf D, Westermann D, Hilgendorf I, von Ehr A.   +14 more
europepmc   +1 more source

PCSK9 : 動脈硬化予防の次なるターゲット(1.Beyond LDL-残存リスクを考える,<特集>第77回日本循環器学会学術集会)

, 2013
剛照 川尻, 正和 山岸
openalex   +2 more sources

A predictive model to assess the risk of developing hyperlipidemia in patients with type 2 diabetes. [PDF]

PLoS One
Ye R, Huang X, Yang H, Pan W, Wang P, Men J, Huang D, Wu S.   +7 more
europepmc   +1 more source

PCSK9 Inhibition With Evolocumab (AMG 145) in Heterozygous Familial Hypercholesterolemia (RUTHERFORD-2): A Randomised, Double-Blind, Placebo-Controlled Trial [PDF]

, 2015
Frederick J. Raal, Evan A. Stein, Robert Dufour   +2 more
openalex   +1 more source

PCSK9 Expression in Vascular Smooth Muscle Cells: Role of Insulin Resistance and High Glucose. [PDF]

Int J Mol Sci
Barale C, Tempesta G, Melchionda E, Morotti A, Frascaroli C, Danzero AC, Femminò S, Penna C, Russo I.   +8 more
europepmc   +1 more source

882 GENETIC VARIATIONS IN proprotein convertase subtilisin/kexin type 9 (PCSK9) GENE ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN IN HEPATITIS C VIRUS GENOTYPE 3-INFECTED PATIENTS

, 2013
Karin Neukam, Antonio Carúz, Antonio Rivero‐Juárez, Pablo Labarga, M. Márquez, Luís Miguel Real, Rocío Herrero, Antonio Rivero, Vincent Soriano, Juan A. Pineda   +9 more
openalex   +1 more source

PCSK9 Inhibition: Does Lipoprotein Size Matter? [PDF]

, 2015
Karim Si‐Tayeb, Bertrand Cariou
openalex   +1 more source

The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes. [PDF]

Sci Rep
Dogan Z, Senyigit A, Durmus S, Duvarcı C, Gelişgen R, Uzun H, Tabak O.   +6 more
europepmc   +1 more source